← Open Payments lookup

DANIELA KANTCHEVA: Open Payments

NPI 1124072350 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,631 in 176 payments from 13 companies in 2025. Trend: 2023 $972 · 2024 $1,262 · 2025 $2,631

Food & beverage: $2,629Education: $1
CompanyPaymentsAmount
ABBVIE INC.35$557
Neurocrine BioSciences, Inc.19$327
Alkermes, Inc.19$309
Otsuka America Pharmaceutical, Inc.18$291
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$243
Vanda Pharmaceuticals Inc.17$217
Janssen Pharmaceuticals, Inc13$183
E.R. Squibb & Sons, L.L.C.20$170
Lundbeck LLC9$152
Teva Pharmaceuticals USA, Inc.4$68

Products named: VRAYLAR, INGREZZA, REXULTI, ARISTADA, CAPLYTA, FANAPT, COBENFY, INVEGA SUSTENNA.

Industry payments across MO — which companies pay providers there.